Illumina, Inc. (NASDAQ: ILMN) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $165.00 price target on the stock, down previously from $190.00.
LowReport
Illumina, Inc. (NASDAQ: ILMN) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $165.00 price target on the stock, down previously from $190.00.
The World Market for Blood Ketone Meters, Forecast to 2029: Discover Regional Business Trends for Human & Veterinary Applications in Hospitals, Diagnostic Centers, Homecare Settings and More [Yahoo! Finance]
LowReport
The World Market for Blood Ketone Meters, Forecast to 2029: Discover Regional Business Trends for Human & Veterinary Applications in Hospitals, Diagnostic Centers, Homecare Settings and More [Yahoo! Finance]
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below: